CMS Clarifies Factors It Will Consider In Negotiating Drug Prices

A new fact sheet released by CMS Friday (Sept. 8) offers more insight into how Medicare’s first round of price negotiations for expensive Medicare Part D drugs will run, coming as drug maker agreements to participate in the program are due Oct. 1. CMS is inviting stakeholders to submit any data related to factors such as therapeutic alternatives to the drugs selected for negotiation , how the selected drugs address unmet medical needs and the impact of selected drugs on...